PLUS THERAPEUTICS, INC. — Director's Dealing 2024

Feb 26, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2024-02-22

Reporting Person: LaFrance Norman D. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-22	Stock Option (Right to Buy)	$2.03	A	24073	Acquired	2034-02-22	Common Stock (24073)	Direct

Footnotes

F1: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement.